Gastrin-Releasing Peptide Receptor Antagonist or N-acetylcysteine combined with Omeprazol Protect against Mitochondrial Complex II Inhibition in a Rat Model of Gastritis

Basic and Clinical Pharmacology and Toxicology

Volumn 108, Issue 3, 2011, Pages 214-219

  Rezin, Gislaine T ^a,b   Petronilho, Fabricia C ^a,b   Araújo, João H ^a,b   Gonçalves, Cinara L ^a,b   Daufenbach, Juliana F ^a,b   Cardoso, Mariane R ^a,b   Roesler, Rafael ^b,c   Schwartsmann, Gilberto ^b,d   Dal Pizzol, Felipe ^a,b   Streck, Emilio L ^a,b  

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d National Institute for Translational Medicine INCT TM   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; GASTRIN RELEASING PEPTIDE RECEPTOR; INDOMETACIN; MITOCHONDRIAL COMPLEX II; OMEPRAZOLE; OXIDOREDUCTASE; RC 3095; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL PROTECTION; CONTROLLED STUDY; DIET RESTRICTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME INHIBITION; GASTRITIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; STOMACH;

ACETYLCYSTEINE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; BOMBESIN; DRUG THERAPY, COMBINATION; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX II; ELECTRON TRANSPORT COMPLEX III; GASTRITIS; INDOMETHACIN; MALE; MITOCHONDRIA; OMEPRAZOLE; PEPTIDE FRAGMENTS; PROTON PUMP INHIBITORS; RATS; RATS, WISTAR; RECEPTORS, BOMBESIN; SEVERITY OF ILLNESS INDEX; STOMACH; STOMACH ULCER;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 79951758245     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2010.00645.x     Document Type: Article

References (37)

1. Schubert ML. Gastric Secretion. Curr Opin Gastroenterol 2002;18:639-49.
2. Yoshikawa T, Naito Y. The role of neutrophils and inflammation in gastric mucosal injury. Free Radic Res 2000;33:785-94.
3. Min YS, Yim SH, Bai KL, Choi HJ, Jeong JH, Song HJ et al. The effects of apigenin-7-O-beta-D-glucuronopyranoside on reflux oesophagitis and gastritis in rats. Auton Autacoid Pharmacol 2005;25:85-91.
4. Bell NJ, Burget D, Howden CW, Wilkinson J, Hunt RH. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 1992;51:59-67.
5. Bell NJ, Hunt RH. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease. Gut 1992;33:118-24.
6. Scarpignato C, Pelosini I. Review article: the opportunities and benefits of extended acid suppression. Aliment Pharmacol Ther 2006;23:23-34.
7. Shina JM, Vagina O, Munsona K, Kiddc M, Modlinc IM, Sachsa G. Molecular mechanisms in therapy of acid-related diseases. Cell Mol Life Sci 2008;65:264-81.
8. Anastasi A, Erspamer V, Bucci M. Isolation and structure of bombesin and alytesin, two analogous active peptides from the skin of the European amphibians Bombesina and Alytes. Experientia 1971;27:166-9.
9. Petronilho F, Roesler R, Schwartsmann G, Dal Pizzol F. Gastrin-releasing peptide receptor as a molecular target for inflammatory diseases. Inflamm Allergy Drug Targets 2007;6:197-200.
10. McDonald TJ, Nilsson G, Vagne M, Ghatei M, Bloom SR, Mutt V. A gastrin releasing peptide from the porcine nonantral gastric tissue. Gut 1978;19:767-74.
11. Sunday ME, Kaplan LM, Motoyama E, Chin WW, Spindel ER. Biology of disease: gastrinreleasing peptide (mammalian bombesin) gene expression in health and disease. Lab Invest 1988;59:5-24.
12. Petronilho F, Araújo JH, Steckert AV, Rezin GT, Ferreira GK, Roesler R et al. Effect of a gastrin-releasing peptide receptor antagonist and a proton pump inhibitor association in an animal model of gastritis. Peptides 2009;30:1460-5.
13. Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid Redox Signal 2005;7:1140-9.
14. Navarro A, Boveris A. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 2007;292:670-86.
15. Coskun E, Ulsal G, Bulut N, Bektas H, Oztekin MF, Yildirim IS. Mitochondrial neurogastrointestinal encephalomyopathy. Gastroenterol 2005;16:163-6.
16. Cheng AM, Morrison SW, Yang DX, Hagen SJ. Energy dependence of restitution in the gastric mucosa. Am J Physiol Cell Physiol 2001;281:C430-8.
17. Szabo S. Mechanisms of gastric mucosal injury and protection. J Clin Gastroenterol 2000;13:S21-34.
18. Horn D, Barrientos A. Mitochondrial copper metabolism and delivery to cytochrome c oxidase. IUBMB Life 2008;60:421-9.
19. Boekema EJ, Braun HP. Supramolecular structure of the mitochondrial oxidative phosphorylation system. J Biol Chem 2007;282:1-4.
20. Jonasescu V. Oculogastrointestinal muscular dystrophy. Am J Med Gen 1983;15:103-12.
21. Mueller LA, Camilleri M, Emslie-Smith AM. Mitochondrial neurogastrointestinal encephalomyopathy: manometric and diagnostic features. Gastroenterology 1999;116:959-63.
22. Dal-Pizzol F, Di Leone LP, Ritter C, Martins MR, Reinke A, Pens Gelain D et al. Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis. Am J Respir Crit Care Med 2006;173:84-90.
23. Gamberini MT, Skorupa LA, Souccar C, Lapa AJ. Inhibition of gastric secretion by a water extract from Baccharis triptera Mart. Mem Inst Oswaldo Cruz 1991;86:137-9.
24. Lowry OH, Rosebough NG, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
25. Cassina A, Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996;328:309-16.
26. Fischer JC, Ruitenbeek W, Berden JA, Trijbels JM, Veerkamp JH, Stadhouders AM et al. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 1985;153:23-6.
27. Rustin P, Chretien D, Bourgeron T, Gérard B, Rötig A, Saudubray JM et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994;228:35-51.
28. Blandizzi C, Fornai M, Colucci R, Natale G, Lubrano V, Vassalle C et al. Lanzoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage. World J Gastroenterol 2005;11:4053-60.
29. Hawkey CJ. Nonsteroidal anti-inflammatory drug gastopathy. Gastroenterology 2000;119:521-35.
30. Naya MJ, Pereboom D, Ortego J, Alda JO, Lanas A. Superoxide anions produced by inflammatory cells play an important part in the pathogenesis of acid and pepsin induced oesophagitis in rabbits. Gut 1997;40:175-81.
31. Gruno M, Peet N, Tein A, Salupere R, Sirotkina M, Valle J et al. Atrophic gastritis: deficient complex I of the respiratory chain in the mitochondria of corpus mucosal cells. J Gastroenterol 2008;43:780-8.
32. Minamino N, Kangawa K, Matsuo H. Neuromedin B: a novel bombesin-like peptide identified in porcine spinal cord. Biochem Biophys Res Commun 1983;114:541-8.
33. Smith VC, Dhatt N, Buchan AMJ. The innervation of the human antro-pyloric region: organization and composition. Can J Physiol Pharmacol 2001;79:905-18.
34. Oliveira PG, Brenol CV, Edelweiss MI, Brenol JCT, Petronilho F, Roesler R et al. Effects of an antagonist of the bombesin/gastrin-releasing peptide receptor on complete Freund's adjuvant-induced arthritis in rats. Peptides 2008;29:1726-31.
35. Moreno-Sánchez R, Bravo C, Vásquez C, Ayala G, Silveira LH, Martínez-Lavín M. Inhibition and uncoupling of oxidative phosphorylation by nonsteroidal anti-inflammatory drugs: study in mitochondria, submitochondrial particles, cells, and whole heart. Biochem Pharmacol 1999;57:743-52.
36. Pastoris O, Verri M, Boschi F, Kastsiuchenka O, Balestra B, Pace F et al. Effects of esomeprazole on glutathione levels and mitochondrial oxidative phosphorylation in the gastric mucosa of rats treated with indomethacin. Naunyn Schmiedebergs Arch Pharmacol 2008;378:421-9.
37. Kim JM, Choi SM, Kim DH, Oh TY, Ahn BO, Kwon JW et al. Combined use of omeprazole and a novel antioxidative cytoprotectant for the treatment of peptic ulcer. Facilitation of ulcer healing in experimental animals. Arzneimittelforschung 2005;55:387-93.